| 000 | 01572 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513224614.0 | ||
| 264 | 0 | _c20010125 | |
| 008 | 200101s 0 0 eng d | ||
| 022 | _a0190-9622 | ||
| 024 | 7 |
_a10.1067/mjd.2000.108369 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHulshof, M M | |
| 245 | 0 | 0 |
_aDouble-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cDec 2000 |
||
| 300 |
_a1017-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCalcitriol _xadministration & dosage |
| 650 | 0 | 4 |
_aCalcium Channel Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aScleroderma, Localized _xdiagnosis |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xdiagnosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBouwes Bavinck, J N | |
| 700 | 1 | _aBergman, W | |
| 700 | 1 | _aMasclee, A A | |
| 700 | 1 | _aHeickendorff, L | |
| 700 | 1 | _aBreedveld, F C | |
| 700 | 1 | _aDijkmans, B A | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 43 _gno. 6 _gp. 1017-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mjd.2000.108369 _zAvailable from publisher's website |
| 999 |
_c11041443 _d11041443 |
||